Page last updated: 2024-11-05

tolbutamide and Nephrosis

tolbutamide has been researched along with Nephrosis in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SCHNALL, C1
WIENER, JS1

Other Studies

1 other study available for tolbutamide and Nephrosis

ArticleYear
Nephrosis occurring during tolbutamide administration.
    Journal of the American Medical Association, 1958, May-10, Volume: 167, Issue:2

    Topics: Humans; Hypoglycemic Agents; Nephrosis; Tolbutamide

1958